The Impact of the FDA’s Single-Registration Pathway on Personalized Therapies, Part 1 Jason Bock, founder and CEO of CTMC, provides his perspective on the FDA’s proposed rule to streamline registration for single distributed manufacturing establishments, and what the change may mean for personalized medicines.